U.S., July 14 -- ClinicalTrials.gov registry received information related to the study (NCT07699926) titled 'Efficacy of PosBion(R) Postbiotic Supplementation in Adults With Irritable Bowel Syndrome' on July 07.
Brief Summary: Irritable bowel syndrome (IBS) is a common functional gastrointestinal disorder characterized by recurrent abdominal pain and altered bowel habits, often associated with impaired intestinal barrier function, low-grade inflammation, and dysregulation of the gut-brain axis. Postbiotics have emerged as a promising therapeutic approach due to their immunomodulatory, anti-inflammatory, and gut barrier-protective properties.
This completed single-arm, open-label clinical study evaluated the efficacy of PosBion(R) postbiot...